BACKGROUND
Dalteparin, a low-molecular-weight heparin, has anticoagulant and anti-angiogenic activity. This study investigated whether dalteparin reduced coronary artery lesion (CAL) prevalence, and resistance to intravenous immunoglobulin (IVIG) therapy in Kawasaki disease (KD).
METHODS
This retrospective study comprised two parts. In the first cohort, 126 patients with KD (68 male, 58 femal...